Tonix Pharmaceuticals Hol...

NASDAQ: TNXP · Real-Time Price · USD
51.66
-7.92 (-13.29%)
At close: Aug 15, 2025, 1:03 PM

Tonix Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-81.42M -131.93M -130.04M -135.25M -149.01M -98.59M -116.66M -121.02M -122.02M -116.81M -110.22M -108.09M -97.64M -98.05M -92.29M -79.75M -73.22M -63.84M
Depreciation & Amortization
1.98M 2.7M 3.42M 4.42M 5.12M 4.84M 4.52M 3.87M 2.9M 2.08M 1.25M 444K 202K 107K 50K 30K 28K 27K
Stock-Based Compensation
4.25M 3.99M 4.78M 5.92M 6.96M 8.17M 9.28M 9.95M 10.64M 11.09M 10.91M 10.49M 10.03M 9.31M 7.9M 6.47M 5.08M 3.73M
Other Working Capital
4.54M 991.02K 1.46M 1.33M 1.68M 4.59M 3.52M 1.95M 1.48M -3.87M -3.9M -2.06M -3.36M -2.06M 2.25M -2.97M -4.48M -3.02M
Other Non-Cash Items
5.5M 63.24M 54.25M 65.32M 65.37M 8.24M 19.1M 17.13M 14.88M 12.71M 14.57M 8.08M 8.76M 9.39M 6.49M 1.83M 2.17M 527K
Deferred Income Tax
n/a n/a n/a -9.01M -9.01M -13.55M -17.56M -17.33M -17.33M -15.16M -11.16M -4.67M -4.67M -2.3M -2.3M 2.37M 2.37M 2.37M
Change in Working Capital
4.85M 2.07M 6.51M 470.51K 7.85M 4.73M -25.63K 5.43M 6.37M 3.72M -2K -1.04M -203K 92K 5.78M 3.23M -4.26M -1.57M
Operating Cash Flow
-64.84M -59.93M -60.92M -67.98M -72.57M -86.01M -101.35M -101.96M -102.11M -99.92M -98.05M -98.2M -87.61M -85.55M -75.56M -67.03M -69.36M -60.3M
Capital Expenditures
-545K -16.23K -118.23K -470.88K -2.27M -4.12M -7.81M -12.13M -19.14M -31.73M -48.15M -69.1M -68.03M -55.02M -35.31M -14.22M -10.48M -9.07M
Cash Acquisitions
n/a n/a n/a 257.05K 1.05M -21.45M -21.45M -21.7M -22.5M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-2.01M 1.77K 1.77K 8.77K 204.98K 529.93K 529.93K 522.93K 324.96K n/a n/a 25.62M 25.62M 25.62M 25.62M n/a n/a n/a
Investing Cash Flow
-2.56M -16.23K -118.23K -213.83K -1.03M -25.05M -28.74M -33.31M -41.31M -31.73M -48.15M -69.1M -68.03M -55.02M -35.31M -14.22M -10.48M -9.07M
Debt Repayment
-11.48M -11.77M -2.35M -1.65M -940K -235K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-6.21M -3.05M n/a n/a n/a n/a -13.96M -13.96M -13.96M -13.96M n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a -4.25M -4.25M -4.25M -4.25M n/a n/a n/a n/a -451K -451K -451K
Other Financial Acitivies
-2.31M -2.77M -2.75M 28.43M 28.43M 31.69M 31.67M 11.64M 7.01M 34.1M 34.14M 22.66M 27.35M 108K 98K 549K 2.9M 2.9M
Financial Cash Flow
188.59M 184.51M 134.76M 90.89M 54.26M 48.38M 37.09M 3.03M -7.87M 63.28M 87.84M 124.38M 166.97M 116.84M 212.49M 208.58M 190.69M 203.06M
Net Cash Flow
121.18M 124.67M 73.83M 21.32M -20.7M -64.17M -94.52M -132.3M -151.36M -68.46M -58.43M -42.99M 11.26M -23.78M 101.59M 127.31M 110.84M 133.69M
Free Cash Flow
-65.39M -59.95M -61.05M -68.46M -74.84M -90.14M -109.16M -114.09M -121.25M -131.65M -146.2M -167.29M -155.64M -140.56M -110.86M -81.25M -79.85M -69.37M